• Has over 25 years of experience in drug discovery in the biopharmaceutical industry
• Served as senior research scientist at Gilead Sciences, Inc.
• Served as associate director of chemical research at Pharmasset Inc.
• During his employment at Pharmasset, Dr. Du, as one of the inventors, participated in the R&D of sofosbuvir (also known as sovaldi), a revolutionary drug for treating hepatitis C which won the Prix Galien Award granted by the Galien Foundation in 2014
• In Jan. 2012, Gilead Sciences, Inc. completed the acquisition of Pharmasset Inc. for about USD 11.2 billion, and thereby obtained sofosbuvir
• Has published 60 academic papers and participated in the invention of more than 300 patents registered worldwide, of which 40 patents had been licensed in the United States